BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17955256)

  • 21. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA.
    Sanada Y; Takata T; Tanaka H; Sakurai Y; Watanabe T; Suzuki M; Masunaga SI
    Int J Radiat Biol; 2021; 97(10):1441-1449. PubMed ID: 34264166
    [No Abstract]   [Full Text] [Related]  

  • 23. Neutron autoradiography to study boron compound microdistribution in an oral cancer model.
    Portu A; Molinari AJ; Thorp SI; Pozzi EC; Curotto P; Schwint AE; Saint Martin G
    Int J Radiat Biol; 2015 Apr; 91(4):329-35. PubMed ID: 25510259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
    Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
    Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
    Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
    BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer.
    Haapaniemi A; Kankaanranta L; Saat R; Koivunoro H; Saarilahti K; Mäkitie A; Atula T; Joensuu H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):404-410. PubMed ID: 26797537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.
    Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
    Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
    Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Low-Dose Gamma Irradiation on the Uptake of Boronophenylalanine to Enhance the Efficacy of Boron Neutron Capture Therapy in an Orthotopic Oral Cancer Model.
    Lin YC; Chou FI; Liao JW; Liu YH; Hwang JJ
    Radiat Res; 2021 Apr; 195(4):347-354. PubMed ID: 33513230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.
    Garabalino MA; Heber EM; Monti Hughes A; González SJ; Molinari AJ; Pozzi EC; Nievas S; Itoiz ME; Aromando RF; Nigg DW; Bauer W; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2013 Aug; 52(3):351-61. PubMed ID: 23591915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
    Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
    Kreimann EL; Itoiz ME; Longhino J; Blaumann H; Calzetta O; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8638-42. PubMed ID: 11751376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.
    Garabalino MA; Monti Hughes A; Molinari AJ; Heber EM; Pozzi EC; Cardoso JE; Colombo LL; Nievas S; Nigg DW; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2011 Mar; 50(1):199-207. PubMed ID: 21132507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas.
    Yamatomo N; Iwagami T; Kato I; Masunaga S; Sakurai Y; Iwai S; Nakazawa M; Ono K; Yura Y
    Radiat Oncol; 2013 Dec; 8():280. PubMed ID: 24295213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
    Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 38. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
    Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.
    Heber EM; Kueffer PJ; Lee MW; Hawthorne MF; Garabalino MA; Molinari AJ; Nigg DW; Bauer W; Hughes AM; Pozzi EC; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2012 May; 51(2):195-204. PubMed ID: 22271404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
    Carpano M; Perona M; Rodriguez C; Nievas S; Olivera M; Santa Cruz GA; Brandizzi D; Cabrini R; Pisarev M; Juvenal GJ; Dagrosa MA
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):344-52. PubMed ID: 26232853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.